| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $17.50M | $70.68M | $93.79M | $61.46M | $42.79M |
| SG&A | $16.68M | $26.09M | $33.30M | $32.55M | $21.23M |
| Operating Income | -$102.27M | -$100.90M | -$125.47M | -$104.02M | -$64.02M |
| Interest Expense | – | – | – | – | $3.00K |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$105.61M | -$96.94M | -$117.67M | -$95.64M | -$54.85M |
| EPS (basic) | -24.7000 | -2.5200 | -3.0900 | -2.5300 | -1.4900 |
| EPS (diluted) | -24.7000 | -2.5200 | -3.0900 | -2.5300 | -1.4900 |
| Shares (diluted) | $4.28M | $38.48M | $38.02M | $37.73M | $36.92M |